In utero exposure to 17alpha-hydroxyprogesterone caproate and risk of cancer in offspring. Murphy CC, Cirillo PM, Krigbaum NY, Cohn BA, et al. Am J Obstet Gynecol 2022;226:132.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Murphy CC, Cirillo PM, Krigbaum NY, Cohn BA, et al. In utero exposure to 17alpha-hydroxyprogesterone caproate and risk of cancer in offspring. Am J Obstet Gynecol 2022;226:132.
PMID: 34767803